“I hope that I can contribute to making the world a better place for patients.”
He came, he saw – and ditched the ties. Gabriel Baertschi is someone who rolls up his sleeves and a forward thinker whose mission dedicated to growing our business and driving our scientific leadership.
Although a trained biologist, his love of science and dedication to improving patient’s lives led him to work for the pharmaceutical industry. Gabriel’s commitment to ensuring our business is sustainable moving forward is hugely valued; he is the epitome of entrepreneurial spirit, courage and diversity.
Originally from Switzerland, he joined the Grünenthal Group in October 2016 as Chairman of the Corporate Executive Board and Chief Executive Officer bringing with him over 20 years of experience in the pharmaceutical industry primarily working for AstraZeneca.
Gabriel Baertschi at a glance
Year of birth: 1974
Education: Harvard Business School, USA: leading enterprise transformation; Université de Neuchâtel, Switzerland: Master of Science in biology; his research received a Nobel Foundation Award and the distinction “Excellent” at the Swiss Youth Research
Family status: Married, one daughter
Leisure time: Family, photography, travelling and scuba diving
Since 2016: Chairman of the Corporate Executive Board and Chief Executive Officer, Grünenthal
2013-2016: Company President Japan, AstraZeneca
2010-2012: Company President Germany, AstraZeneca
2009-2010: Company President Thailand, AstraZeneca
2006-2009: General Manager Vietnam & Indonesia, AstraZeneca
Since 2021: Member of the Board of MedXCell, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible new therapies utilizing the unique powers of living cells